Surgeons Grow 3D-Printed Nose On Woman's Arm After She Lost Hers To Cancer – This And More News In Digital Health This Week
Bertalan Meskó, MD, PhD
The Medical Futurist, Author of Your Map to the Future, Global Keynote Speaker, and Futurist Researcher
What a major breakthrough from a French surgical team to successfully transplant a nose grown on the patient's forearm. It's so great to see 3D bioprinting being implemented into more traditional surgical reconstruction methods.
On a non-medical note: as the last instalment of our book review series, here is the final episode, about my absolute favourites from 2022. Two non-fiction and two fiction, maybe it's some inspiration before the holiday season.
"The operation involved ear, nose and throat experts as well as plastic surgery teams at the Toulouse University Hospital and the Claudius Regaud Institute and took place at the Toulouse-Oncopole University Cancer Institute.
They said that they managed to successfully re-vascularise the patient’s nasal cavity, connecting the blood vessels by performing microsurgery."
I graduated as a genetic specialist and completed my PhD as a clinical genomics researcher. My original field never ceases to fascinate me. I’m curious about how these tests advance and hope to provide insights for patients worldwide about what they can expect to learn from such tests.
Pathway analysis coupled with good counselling offers real practical knowledge. This might be the best test I've ever tried in terms of usefulness. The downside: it's only available in the US and South Africa.
Artificial intelligence will be one of the major forces fundamentally transforming healthcare in the 21st century.
In the latest update of our AI book, we summarized everything there is to know about its potential, the use cases and about what we can and can't expect from algorithms.
Just 3 months after the US Food and Drug Administration approved the first cell-based gene therapy for treating Beta-thalassemia, a disorder requiring regular blood transfusions, now they have approved the first gene therapy for hemophilia B!
"The therapy, called Hemgenix and developed by the Dutch biotechnology company UniQure, is for the less common “B” form of hemophilia, which is estimated to represent about 15% of all patients with the disease."
领英推荐
If you follow The Medical Futurist's social media channels, you're undoubtedly aware that I'm an avid reader who spends hours browsing through reviews to select the next book to read.
This time, I'd like to present my favorite books from this year! I have chosen two works of science fiction and two works of nonfiction.
Of course, patients prefer telehealth for common illnesses! Why would they want to stand in line with other sick people when they only need medical advice they could get in a 3-minute telehealth visit?
However, it doesn't mean that providing telehealth visits is easy. It's a new situation for patients and physicians alike, and they both have to learn how to build relationships through such technology.
Elizabeth Holmes, the founder of the blood-testing startup Theranos, was found guilty and sentenced to more than 11 years in prison for defrauding investors.
One of the biggest scandals, and indeed the biggest scam of the digital health era, is over.
MORE NEWS ABOUT THE FUTURE OF MEDICINE
TACKLE COPD – Activity tracker data can shed light on heart health